George Scangos
2021
In 2021, George Scangos earned a total compensation of $20.7M as President and Chief Executive Officer at Vir Biotechnology, a 1,979% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $487,000 |
---|---|
Option Awards | $12,129,858 |
Salary | $575,000 |
Stock Awards | $7,479,180 |
Other | $11,600 |
Total | $20,682,838 |
Scangos received $12.1M in option awards, accounting for 59% of the total pay in 2021.
Scangos also received $487K in non-equity incentive plan, $575K in salary, $7.5M in stock awards and $11.6K in other compensation.
Rankings
In 2021, George Scangos' compensation ranked 305th out of 12,415 executives tracked by ExecPay. In other words, Scangos earned more than 97.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 305 | 98th |
Manufacturing | 92 | 98th |
Chemicals And Allied Products | 28 | 99th |
Drugs | 24 | 99th |
Biological Products, Except Diagnostic Substances | 11 | 98th |
Scangos' colleagues
We found four more compensation records of executives who worked with George Scangos at Vir Biotechnology in 2021.